Open Access

PYGB siRNA inhibits the cell proliferation of human osteosarcoma cell lines

  • Authors:
    • Shuwei Zhang
    • Yichi Zhou
    • Yuanyu Zha
    • Yang Yang
    • Linlong Wang
    • Jingfeng Li
    • Wei Jin
  • View Affiliations

  • Published online on: May 16, 2018     https://doi.org/10.3892/mmr.2018.9022
  • Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: HTML 0 views | PDF 0 views     Cited By (CrossRef): 0 citations

Abstract

Osteosarcoma is the most common malignant bone carcinoma that primarily occurs between childhood to adolescence. It was suggested by recent research that the Brain type glycogen phosphorylase (PYGB) gene may serve an important role in various types of cancer. In the present study, the PYGB gene was knocked down in order to evaluate the cell viability, invasion and migration of the human osteosarcoma cell lines MG63 and HOS. The expression levels of PYGB in osteosarcoma and bone cyst tissue samples, as well as in the osteosarcoma cell lines were identified using reverse transcription‑quantitative polymerase chain reaction and western blot assay. Subsequently, a Cell Counting kit 8 assay was employed to evaluate cell proliferation. Cell apoptosis rate and cell cycle distribution were measured by flow cytometry. In addition, cell invasion and migration were evaluated through a Transwell assay. The expression levels of the cell apoptosis and tumor metastasis associated proteins B‑cell lymphoma 2 (Bcl‑2), Bcl‑2‑associated X protein, E‑cadherin, Twist, matrix metalloproteinase (MMP)‑9 and MMP2 were measured via western blotting. PYGB exhibited a higher expression level in the osteosarcoma tissue samples, particularly in the human osteosarcoma cell lines MG63 and HOS. Knockdown of PYGB resulted in a decline in cell proliferation, invasion and migration, which was coupled with induced cell apoptosis and cell cycle arrest in MG63 and HOS cells. Furthermore, alterations in the expression of apoptosis and metastasis associated proteins indicated that small interfering (si)PYGB may have regulated cell viability by targeting the Bcl/Caspase and cyclin dependent kinase (CDK)‑1 signaling pathway. In conclusion, PYGB siRNA exerted an inhibitory effect on the cell viability of the human osteosarcoma cells MG63 and HOS by blocking the Caspase/Bcl and CDK1 signaling pathway, highlighting novel potential therapeutic methods for treating osteosarcoma.

Related Articles

Journal Cover

Print ISSN: 1791-2997
Online ISSN:1791-3004

2016 Impact Factor: 1.692
Ranked #19/128 Medicine Research and Experimental
(total number of cites)

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Zhang, S., Zhou, Y., Zha, Y., Yang, Y., Wang, L., Li, J., & Jin, W. (1899). PYGB siRNA inhibits the cell proliferation of human osteosarcoma cell lines. Molecular Medicine Reports, 0, 0-0. https://doi.org/10.3892/mmr.2018.9022
MLA
Zhang, S., Zhou, Y., Zha, Y., Yang, Y., Wang, L., Li, J., Jin, W."PYGB siRNA inhibits the cell proliferation of human osteosarcoma cell lines". Molecular Medicine Reports 0.0 (1899): 0-0.
Chicago
Zhang, S., Zhou, Y., Zha, Y., Yang, Y., Wang, L., Li, J., Jin, W."PYGB siRNA inhibits the cell proliferation of human osteosarcoma cell lines". Molecular Medicine Reports 0, no. 0 (1899): 0-0. https://doi.org/10.3892/mmr.2018.9022